Based on our advanced algorithm, we predict that GLUE stock price will experience significant movement in the coming periods. Our 1-day prediction estimates a price of $4.44, while the 1-week outlook suggests a value of $4.21. For the 1-month forecast, we project a price of $4.35. Looking further ahead, our 2026 projection estimates a value of $6.63, with a long-term 2030 forecast reaching $167.16. Stay informed and make strategic decisions with our data-driven insights!
Based on our evaluation of the five key dimensions—Technical Signals, Moving Average trends, Short Sell Data, Similar Chart Pattern Matching and Seasonality Analysis—we have identified the following insights. GLUE has several negative signals and is within a falling trend, so we believe it will perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Our analysis conclusion for this stock is a Strong Sell candidate.
GLUE stock price ended at $4.19 on Monday, after losing-4.34%
The Monte Rosa Therapeutics Inc stock price decreased by -4.34% on the last trading day (11 Aug 2025), dropping from 4.37 to 4.19. Throughout the last trading session, the stock experienced a fluctuation of 6.75% , ranging from a day low of $4.15 to a day high of 4.43. The price has declined in 7 of the last 10 days, resulting in a total change of -24.50% during this period. On the last day, trading volume increase by 27.61K shares, with the falling prices. This could serve as an early warning, indicating that risk may slightly increase in the coming days. In total, 432.50K shares were traded, amounting to approximately 1.85M.
GLUE Technical Signals
GLUE(Monte Rosa Therapeutics Inc Corp) has 4 buy signals and 5 sell signals now. The current trend is uptrend starting from 2025-06-20. The total price change during this trend is -9.50%. Recently, the price has decreased but the volume has also decreased, indicating a potential rebound signal. The average turnover of GLUE over the last 5 trading days is 1.76M. Overall, the technical indicator signals lean more toward a Neutral outlook in the mid-term.
Monte Rosa Therapeutics Inc's overall moving average trend leans more bearish as of Tuesday, August 12, 2025, with 3 negative signals and 1 positive signal. In the mid-term, the SMA_20 being above the SMA_60 signals a strong bullish trend. There will be some resistance from the lines at $5.77, and $6.35. A break-up above any of these levels will issue buy signals. There will be some support from the lines at $3.90, and $3.32. A break-down below any of these levels will issue sell signals.
GLUE Short Selling Analysis
The short sale ratio of Monte Rosa Therapeutics Inc(GLUE) as of 08 Aug 2025 is 10.58%, dropping from last trading day. With decreasing price from 4.23 to 4.38. The short sell activity indicate that short sellers may be experiencing short cover.
Technical Signal
Technical Signals Summary
Neutral
Sell
5
Buy
4
Moving Average
Swing
Negative
Stock Price Below SMA_5
Short Term
Negative
SMA_5 Below SMA_20
Mid Term
Positive
SMA_20 Above SMA_60
Long Term
Negative
SMA_60 Below SMA_200
Short Selling
Close Price
Short Sale Ratio
Short Sale Volume
4 Bullish Signals
4 Bullish Signals
When Value satisfies Signal, Indicator signals Bullish
Indicators
Signal
Value
Meaning
Stochastic Oscillator %K (14, 3, 3)
STOCHk_14_3_3 < 20
6.782
Bullish
Commodity Channel Index (20 days, 0.015 constant)
CCI_20_0.015 < -100
-132.338
Bullish
Stochastic RSI %K (14, 14, 3, 3)
STOCHRSIk_14_14_3_3 < 20
4.394
Bullish
Williams %R (14 days)
WILLR_14 < -80
-96.392
Bullish
5 Bearish Signals
5 Bearish Signals
When Value satisfies Signal, Indicator signals Bearish
In 2026, Monte Rosa Therapeutics Inc (GLUE) is anticipated to change hands in a trading channel between $2.17 and $16.08.
Monte Rosa Therapeutics Inc Stock Forecast 2026
Jan 2026: GLUE Stock Forecast
Potential ROI: 51.16%
In Jan 2026, Monte Rosa Therapeutics Inc's value is forecasted to reach an average price of $7.21. The price is predicted to fluctuate between a low of $2.17 and a high of $10.73.
Feb 2026: GLUE Stock Forecast
Potential ROI: 118.52%
In Feb 2026, Monte Rosa Therapeutics Inc's value is forecasted to reach an average price of $10.42. The price is predicted to fluctuate between a low of $8.45 and a high of $11.15.
Mar 2026: GLUE Stock Forecast
Potential ROI: 109.44%
In Mar 2026, Monte Rosa Therapeutics Inc's value is forecasted to reach an average price of $9.99. The price is predicted to fluctuate between a low of $7.35 and a high of $11.47.
Apr 2026: GLUE Stock Forecast
Potential ROI: 71.13%
In Apr 2026, Monte Rosa Therapeutics Inc's value is forecasted to reach an average price of $8.16. The price is predicted to fluctuate between a low of $3.97 and a high of $9.32.
May 2026: GLUE Stock Forecast
Potential ROI: 114.14%
In May 2026, Monte Rosa Therapeutics Inc's value is forecasted to reach an average price of $10.21. The price is predicted to fluctuate between a low of $6.02 and a high of $13.68.
Jun 2026: GLUE Stock Forecast
Potential ROI: 140.94%
In Jun 2026, Monte Rosa Therapeutics Inc's value is forecasted to reach an average price of $11.49. The price is predicted to fluctuate between a low of $8.36 and a high of $16.08.
Jul 2026: GLUE Stock Forecast
Potential ROI: 74.58%
In Jul 2026, Monte Rosa Therapeutics Inc's value is forecasted to reach an average price of $8.33. The price is predicted to fluctuate between a low of $3.68 and a high of $8.70.
Aug 2026: GLUE Stock Forecast
Potential ROI: 39.04%
In Aug 2026, Monte Rosa Therapeutics Inc's value is forecasted to reach an average price of $6.63. The price is predicted to fluctuate between a low of $3.62 and a high of $10.44.
Sep 2026: GLUE Stock Forecast
Potential ROI: 39.04%
In Sep 2026, Monte Rosa Therapeutics Inc's value is forecasted to reach an average price of $6.63. The price is predicted to fluctuate between a low of $5.36 and a high of $10.24.
Oct 2026: GLUE Stock Forecast
Potential ROI: 39.04%
In Oct 2026, Monte Rosa Therapeutics Inc's value is forecasted to reach an average price of $6.63. The price is predicted to fluctuate between a low of $2.74 and a high of $7.74.
Nov 2026: GLUE Stock Forecast
Potential ROI: 120.71%
In Nov 2026, Monte Rosa Therapeutics Inc's value is forecasted to reach an average price of $10.53. The price is predicted to fluctuate between a low of $8.46 and a high of $12.50.
Dec 2026: GLUE Stock Forecast
Potential ROI: 116.37%
In Dec 2026, Monte Rosa Therapeutics Inc's value is forecasted to reach an average price of $10.32. The price is predicted to fluctuate between a low of $7.18 and a high of $14.75.
GLUE Price Prediction & Forecast by Similar Chart Analysis
Based on historical patterns and backtesting of stocks with similar movements to Monte Rosa Therapeutics Inc(GLUE), our algorithm predicts GLUE's 1-month price at $4.77, with an 8.88%upwardshift. Using a similarity score up to 96.12%and other factors, This forecast updates weekly, adjusting for significant deviations.
Similar Chart
The price prediction chart for Monte Rosa Therapeutics Inc (GLUE.O) stock, as of Sunday, August 10, 2025 , forecasts a 8.88% change over the next month, based on its high correlation with BVS.O stock patterns. The similarity between their price movements over the analyzed periods is 96.12%. The right panel lists other stocks with similar price patterns. This prediction is updated every week.
Based on GLUE's historical stock price data across all years, the probability of a positive return in August is40.00%, suggesting it maynotbe an ideal month to invest in GLUE. In contrast,Julyoffers the highest probability of positive returns at75.00%, making it a potentially strong month for investment.
However, this is only a prediction based on one method, and a comprehensive assessment of the stock's future trend should consider additional factors. Our final stock price commentary incorporates three main evaluation dimensions: technical signals, Moving Average trends, and similar chart pattern matching, with the first two dimensions carrying the primary weight to ensure a more robust and accurate forecast.
Monthly Seasonality
The radar chart shows that buying Monte Rosa Therapeutics Inc (GLUE.O) stock in July has the highest probability of a positive return (75.00%), while January has the lowest probability (0.00%).
Performance Seasonality
The chart shows Monte Rosa Therapeutics Inc. (GLUE)'s annual stock price return for the past three years, helping you analyze price trends and identify recurring trends on an annual basis.
Should I buy Monte Rosa Therapeutics Inc (GLUE.O) stock?
Based on our evaluation of the five key dimensions—Technical Signals, Moving Average trends, Short Sell Data, Similar Chart Pattern Matching and Seasonality Analysis—we have identified the following insights. GLUE has several negative signals and is within a falling trend, so we believe it will perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Our analysis conclusion for this stock is a Strong Sell candidate.
Which months have the highest win rate for buying Monte Rosa Therapeutics Inc (GLUE.O) stock in a year?
The radar chart shows that buying Monte Rosa Therapeutics Inc (GLUE.O) stock in July has the highest probability of a positive return (75.00%), while January has the lowest probability (0.00%).
How has Monte Rosa Therapeutics Inc. (GLUE)'s stock price performed over the past three years?
GLUE's stock price fell by -27.38% in 2023,increased by 21.54% in 2024, and went down by 41.07%in 2025.
Bearish technical signals of GLUE include: AO_5_34 < 0, MOM_10 < 0, MACD_12_26_9 < 0, close < fibonacci_S1, 10-day SMA crosses below 60-day SMA.
Is GLUE a buy based on overall technical signals summary?
GLUE has 4 buy signals and 5 sell signals now. Overall the technical rating for GLUE is Neutral . Note that market conditions change all the time. In addition to technical ratings, keep an eye on the Valuation Level of GLUE.
What is the trend of Monte Rosa Therapeutics Inc (GLUE)'s moving average?
Monte Rosa Therapeutics Inc's overall moving average trend leans more bearish as of August 12 2025, with 3 negative signals and 1 positive signal.
What is price prediction for GLUE stock next month?
The price prediction chart for Monte Rosa Therapeutics Inc (GLUE.O) stock, as of August 10 2025, forecasts a 8.88% change over the next month, based on its high correlation with BVS stock patterns. The similarity between their price movements over the analyzed periods is 96.12%. The right panel lists other stocks with similar price patterns. This prediction is updated every week.
What is price prediction 2025 for GLUE Stock?
The price prediction for GLUE stock in 2025 is $6.20, driven by positive insider activity and strong institutional interest. The stock is currently undervalued at $4.38, with technical indicators suggesting a potential rebound.
What is price prediction 2030 for GLUE Stock?
I'm sorry, but I couldn't find relevant data to provide a price prediction for GLUE stock by 2030. Please feel free to ask another question or provide more details.